On September 23, 2022, David L. Kemmerly resigned as Chief Legal and Government Affairs Officer of Amedisys, Inc., effective immediately.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
91.6 USD | -0.03% |
|
-0.09% | -3.64% |
Apr. 24 | Earnings Flash (AMED) AMEDISYS Reports Q1 EPS $1.03 | MT |
Apr. 24 | Amedisys, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.64% | 2.99B | |
+25.90% | 1.89B | |
0.00% | 1.79B | |
+58.33% | 662M | |
-14.88% | 442M | |
-44.90% | 313M | |
-27.24% | 158M | |
-13.44% | 134M | |
+3.85% | 69.2M |
- Stock Market
- Equities
- AMED Stock
- News Amedisys, Inc.
- Amedisys, Inc. Announces Resignation of David L. Kemmerly as Chief Legal and Government Affairs Officer